Triple_Barrel_Capital

$SRPT Oversold at Support

看多
NASDAQ:SRPT   Sarepta Therapeutics, Inc.
$SRPT RSI looking oversold on the daily chart, held trend line support well today. Expecting a bounce in the near/medium term.
Targeting $160 at least by next earnings release late October.




Note: Informational analysis, not investment advice.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。